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(D-Ala2,D-LeuS)enkephalinamide and its (Ala2), (LeuS) and (Ala2,LeuS) diastereomers have been prepared 
by direct coupling of enzymatic and azide methods of peptide bond formation. The low nucleophile r activi- 
ty of D-amino acid derivatives has been overcome by an iterative enzymatic synthesis in a nucleophile pool. 
A striking difference in the biological activity of the chirally pure diastereomeric enkephalinamides has been 
observed. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The chiral specificity of proteases decreases but 
does not prevent the enzymatic hydrolysis of pep- 
tides containing D-amino acids [1,2]. This is rele- 
vant for the design and preparation of stable phar- 
macologically active peptides which, however, are 
not resistant to enzymatic hydrolysis. 
The discovery of the endogenous opioid pen- 
tapeptides (Let?)- and (Met’)enkephalins [3] coin- 
cided in time with the revival of interest in en- 
zymatic peptide synthesis [4]. This accounts for the 
reported synthesis of these peptides by enzymatic 
fragment condensation [5] and by enzyme syn- 
thesis of the 4 peptide bonds [6]. Natural 
enkephalins can also be prepared by recombinant 
DNA technology [7], but they are not stable 
against degradation by tissue enkephalinases [8]. 
Here we report the incorporation of D-amino acids 
into (Leu5)enkephalinamide by direct coupling of 
the enzymatic and azide methods for the formation 
of peptide bonds. 
* To whom correspondence should be addressed 
The enzymes mu-chymotrypsin and thermolysin 
were purchased from Boehringer Mannheim. 
Z-amino acids and amino acid methyl esters 
were prepared by the classical methods of peptide 
chemistry [9]; amino acid hydrazides (free base) 
were obtained by direct hydrozinolysis of the 
amino acid esters [lo]. 
Enzymatic peptide bond synthesis was carried 
out by an iterative procedure in a nucleophile pool 
described previously [l I]. A quantity of an amine 
component, calculated on the basis of the known 
nucleophile specificity of the enzymes used [ 12,131, 
was dissolved in 0.2 M carbonate/bicarbonate 
buffer, pH 9.3 (chymotrypsin), or 0.2 M maleate 
buffer, pH 6.8 (thermolysin). Enzyme (10 mg) was 
then added, followed by the acyl component. After 
the conversion of the latter the product was filtered 
and the synthesis was repeated several times by an 
iterative addition of equivalent amounts of acyl 
and amine components to the filtrate. The pro- 
ducts were pooled and recrystallized from 
MeOH/HzO. 
The Honzl-Rudinger [14] procedure was used 
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for azide fragment condensation. The crude pro- 
ducts were recrystallized from EtOH/petroleum 
ether. 
Deblocking of Z-peptides was done by 
hydrogenolysis in the presence of palladized char- 
coal. Following deprotection, the resulting pep- 
tides were obtained as their hydrochlorides from 
MeOH/EtzO. 
The homogeneity of the intermediate and final 
products was assessed by ascending thin-layer 
chromatography (Merck silica plates), amino acid 
analysis (AAA 881 analyzer) and elemental 
analysis; their structures were confirmed by ‘H- 
NMR spectroscopy (Bruker WH 250 MHz) in 
DMSO-d6. 
The biological activity of the synthesized 
enkephalin analogs was determined by a naloxone- 
reversible inhibition of electrically-induced con- 
tractions of segments from guinea pig distal ileum 
WI. 
3. RESULTS AND DISCUSSION 
A synthetic scheme for (D-Ala’,D-Leu’)en- 
kephalinamide is shown in fig. 1, the strategy for 
preparation of (D-Ala2,Leu5)-, (Ala’,D-LeuS)- and 
(Ala2,Leu5)enkephalinamides being strictly iden- 
tical. The chemical-enzymatic synthesis involves a 
kinetically controlled enzyme aminolysis of Z-Tyr- 
OMe by H-D-Ala-NHNH2, followed by azide 
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coupling of the resulting Z-Tyr-D-Ala-NHNHZ 
with the tripeptide H-Gly-Phe-D-Leu-NH~. The 
latter was obtained by thermodynamically con- 
trolled enzyme condensation of Z-Gly-OH with H- 
Phe-OMe, followed by a kinetically controlled en- 
zyme aminolysis of the resulting Z-Gly-Phe-OMe 
by H-D-Leu-NH2. 
Due to the radical change of the enzyme- 
nucleophile interactions, H-D-Ala-NHNH2 and D- 
H-Leu-NH2 react much more slowly than the cor- 
responding L-enantiomers. The ratio of the 
aminolysis rate constants (table l), 
(k~/k~)/(k~/k~) = k,L/klS), 
suggests that, to favour synthesis, D-enantiomer 
should be used in a several times higher concentra- 
tion than L-enantiomer for the same preparative 
yield. 
In the case of such low nucleophile specificity, 
effective enzyme synthesis is easily achieved by an 
iterative addition of equivalent amounts of acyl 
and amine components to a solution (nucleophile 
pool) containing the enzyme and calculated for the 
highest possible yield quantity of the nucleophile 
[ 111. Thus, Z-Tyr-D-Ala-NHNH2 and Z-Gly-Phe- 
D-Leu-NH2 were obtained with an 80% yield by a 
chymotrypsin-catalyzed synthesis (fig. 1). The same 
method, applied in the thermolysin synthesis of Z- 
Gly-Phe-OMe, resulted in a 65% yield (fig.1). 
Since proteases exhibit no epimerase activity, the 
chiral integrity of the final products is controlled 
by the azide fragment condensation (fig-l). ‘H- 
NMR chemical shifts of the diastereomeric 
enkephalinamides are reported in table 2. As table 
2 shows, the separation between the signals of the 
diastereomeric pairs is up to 42.5 Hz at 250 MHz; 
Table 1 
Nucleophile reactivity in ~hymotrypsin synthesis of 
diastereorneric fragments of enkepha~inamides (fig. 1) 
Nucleophile kJk,va k,L/k:: 
H-L-Ala-NHNHz 1100 f 50 
H-D-Ala-NHNH2 270 + 20 4.0 
H-L-Leu-NH2 4280 + 250 
H-D-Leu-NH2 500 f 40 8.5 
a Ratio of the rate constants for aminolysis (kn) and 
hydrolysis (k,) of acylchymotrypsin [I 11 
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hence, NMR is excellent for diastereomeric mix- 
ture analysis. No signals of contaminating epimers 
have been observed, indicating the chiral purity of 
the prepared enkephalin analogs. This is supported 
by the fact that they display the highest inhibitory 
potency (lowest ICSO values) reported in the 
literature (table 3). The striking difference in the 
ICsO values of the diastereomeric enkephalin- 
amides suggests that any diastereomeric impurities 
would greatly affect their biological activity. The 
present study would therefore indicate that enzyme 
incorporation of D-amino acids into peptides en- 
sues preparation of chirally pure, biologically ac- 
tive peptides. 
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6 
@pm) 
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C”H 1.05(3) 1.22(3) 0.17 
LeuS NH 7.99(l) 0.05(l) 0.06 
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b 1171 
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19000 
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